학술논문
First-in-human phase I study of MP0250, a first-in-class DARPin drug candidate targeting VEGF and HGF, in patients with advanced solid tumors
Document Type
Article
Author
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 10 January 2021, 39(2):145-154)
Subject
Language
English
ISSN
15277755
0732183X
0732183X